Enthea

Enthea offers evidence-based mental health treatments, including ketamine-assisted therapy (KAT) and stellate ganglion block (SGB), through comprehensive benefit plans to improve employee well-being and reduce healthcare costs. The company integrates this therapy into corporate benefits packages, providing a rapid and effective alternative to traditional treatments for depression, PTSD, substance abuse, and acute anxiety. Enthea leverages a network of credentialed providers to deliver high-quality care, aiming to improve employee well-being while potentially reducing overall healthcare costs.